Business Description
Episurf Medical AB
ISIN : SE0003491562
Share Class Description:
LTS:0QUT: Class BTotal Employee Number:
21Compare
Compare
Traded in other countries / regions
EPIS B.Sweden0QUT.UK16E.GermanyEPSFF.USA IPO Date
2014-06-13Description
Episurf Medical AB is a medical device company. The company develops, manufactures, and commercializes solutions for the repair of the local cartilage damage in human joints. Its first patient-specific product portfolio, the knee portfolio, consists of the existing products Episealer Condyle Solo and Episealer Trochlea Solo, Episealer Femoral Twin, Epiguide MOS, and Epioscopy. Episealer Patellofemoral System for the treatment of osteoarthritis limited to thepatellofemoral part of the knee joint. The company is forming a new strategic business segment through the acquisition of real estate assets.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 2.84 | |||||
Equity-to-Asset | 0.77 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.08 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 0.84 | |||||
Beneish M-Score | 0.48 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 2.5 | |||||
3-Year EBITDA Growth Rate | 28.4 | |||||
3-Year EPS without NRI Growth Rate | 26.6 | |||||
3-Year FCF Growth Rate | 26.6 | |||||
3-Year Book Growth Rate | -56.4 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 120.51 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 0.97 | |||||
9-Day RSI | 10.45 | |||||
14-Day RSI | 23.18 | |||||
3-1 Month Momentum % | 49.35 | |||||
6-1 Month Momentum % | 191.19 | |||||
12-1 Month Momentum % | 121.5 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.34 | |||||
Quick Ratio | 0.32 | |||||
Cash Ratio | 0.1 | |||||
Days Inventory | 165.09 | |||||
Days Sales Outstanding | 134.41 | |||||
Days Payable | 817.6 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -48.4 | |||||
Shareholder Yield % | -3.69 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 48.41 | |||||
Operating Margin % | -569.05 | |||||
Net Margin % | -543.65 | |||||
EBITDA Margin % | -442.86 | |||||
FCF Margin % | -273.02 | |||||
OCF Margin % | -228.57 | |||||
ROE % | -43.89 | |||||
ROA % | -33.83 | |||||
ROIC % | -37.56 | |||||
3-Year ROIIC % | 685.71 | |||||
ROC (Joel Greenblatt) % | -1048.17 | |||||
ROCE % | -37.71 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 5.34 | |||||
PB Ratio | 0.26 | |||||
Price-to-Tangible-Book | 0.3 | |||||
EV-to-EBIT | -6.02 | |||||
EV-to-EBITDA | -6.81 | |||||
EV-to-Revenue | 30.11 | |||||
EV-to-FCF | -11.4 | |||||
Price-to-GF-Value | 1.13 | |||||
Price-to-Median-PS-Value | 0.13 | |||||
Earnings Yield (Greenblatt) % | -16.62 | |||||
FCF Yield % | -8.87 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Episurf Medical AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 12.6 | ||
| EPS (TTM) (kr) | -0.05 | ||
| Beta | -0.8104 | ||
| 3-Year Sharpe Ratio | -0.05 | ||
| 3-Year Sortino Ratio | -0.11 | ||
| Volatility % | 236.96 | ||
| 14-Day RSI | 23.18 | ||
| 14-Day ATR (kr) | 0.003302 | ||
| 20-Day SMA (kr) | 0.06895 | ||
| 12-1 Month Momentum % | 121.5 | ||
| 52-Week Range (kr) | 0.0294 - 0.272 | ||
| Shares Outstanding (Mil) | 6,930.84 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Episurf Medical AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Episurf Medical AB Stock Events
| Event | Date | Price (kr) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-13 | In 112 days | ||
| Second quarter earnings results for 2026 | 2026-08-24 | In 31 days | ||
| General meeting for 2026 | 2026-05-25 15:00 | 0.16 (+2.81%) | ||
| First quarter earnings results for 2026 | 2026-05-25 | 0.16 (+2.81%) | ||
| Annual report for 2025 | 2026-03-20 | 0.06 (+0.00%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-06 | 0.06 (+0.00%) | ||
| Third quarter earnings results for 2025 | 2025-10-24 | 0.04 (+0.00%) | ||
| Second quarter earnings results for 2025 | 2025-07-11 | 0.05 (+0.00%) | ||
| General meeting for 2025 | 2025-04-10 16:30 | 0.09 (+0.00%) | ||
| First quarter earnings results for 2025 | 2025-04-10 | 0.09 (+0.00%) |
Show
Entries
Episurf Medical AB Frequently Asked Questions
What is Episurf Medical AB(LTS:0QUT)'s stock price today?
The current price of LTS:0QUT is kr0.06. The 52 week high of LTS:0QUT is kr0.27 and 52 week low is kr0.03.
When is next earnings date of Episurf Medical AB(LTS:0QUT)?
The next earnings date of Episurf Medical AB(LTS:0QUT) is 2026-08-24.
Does Episurf Medical AB(LTS:0QUT) pay dividends? If so, how much?
Episurf Medical AB(LTS:0QUT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Episurf Medical AB
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers